These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15088322

  • 1. Low-dose aspirin in polycythemia vera.
    Dutrillaux F, Maynadié M, Carli PM.
    N Engl J Med; 2004 Apr 15; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088322
    [No Abstract] [Full Text] [Related]

  • 2. Low-dose aspirin in polycythemia vera.
    Denes AE.
    N Engl J Med; 2004 Apr 15; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088323
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Essential thrombocythemia: antiaggregants].
    Cortelazzo S, Barbui T.
    Haematologica; 1991 Jun 15; 76 Suppl 3():371-3. PubMed ID: 1752535
    [No Abstract] [Full Text] [Related]

  • 5. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH.
    Platelets; 2006 Dec 15; 17(8):528-44. PubMed ID: 17127481
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose aspirin in polycythemia vera.
    Alliot C.
    N Engl J Med; 2004 Apr 15; 350(16):1683-5; author reply 1683-5. PubMed ID: 15084704
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr 15; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aspirin in polycythemia vera and essential thrombocythemia: current facts and perspectives.
    Landolfi R, Patrono C.
    Leuk Lymphoma; 1996 Sep 15; 22 Suppl 1():83-6. PubMed ID: 8951777
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pathogenesis and management of bleeding in essential thrombocythemia and polycythemia vera.
    Elliott MA, Tefferi A.
    Curr Hematol Rep; 2004 Sep 15; 3(5):344-51. PubMed ID: 15341701
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.
    Griesshammer M, Struve S, Barbui T.
    Blood Rev; 2008 Sep 15; 22(5):235-45. PubMed ID: 18617299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.